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Abstract 
 
The design of novel self-assembling biomaterials that change morphology in response to 
specific stimuli can lead to much advancement in designing next generation sensors, diagnostic 
and therapeutic agents. We have previously developed a new class of self-assembling materials 
known as peptide amphiphiles (PA) that transform from spherical micelles to nanofibers in the 
slightly acidic environment of cancerous tissue, as a novel mechanism to enhance their 
accumulation at the tumor site relative to normal tissue. A typical PA that we construct consists 
of an alkyl tail, followed by an amino acid sequence, and terminated with a MRI imaging agent.  
However, designing this vehicle that will transform under a specific pH value in vivo requires a 
more detailed understanding of the relative attractive hydrophobic and the repulsive electrostatic 
forces in these surfactant-like molecules. Here, we specifically studied how  the alkyl chain 
length, the number of anionic amino acids in the molecule’s charged region, and the number of 
tyrosine (Y) residues in the its beta sheet region affect the sphere to nanofiber transition pH, 
starting from palmitoyl-YYAAEEEEK(DO3A:Gd)-NH2. In general, it was shown that increasing 
the alkyl chain length promotes nanofiber formation under a given set of conditions, while 
increasing the number of charged amino acids promotes micelle formation. Furthermore, it was 
determined that the addition of a fifth glutamic acid shifts the pH of the sphere to nanofiber 
transition to a slightly more acidic value as compared to the deletion of a single methylene group 
or tyrosine residue. 
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Chapter 1: Introduction 
 
Cancer is one of the most prevalent diseases in the world, accounting for over 8.2 million 
deaths worldwide in 2012
1
.  The World Health Organization (WHO) estimates that the number 
of annual cancer cases will rise by 8 million in the next twenty years
2
.  With these staggering 
statistics, there is much interest in the biomedical community to develop new methods of treating 
and detecting cancer.  For example, the development of new biomaterials for drug delivery via 
the recognition of specific biomarkers in cancer has received much attention for its targeted 
therapeutic effects
3-7
.  There is also an interest in the development of stimuli responsive 
molecules for the detection and treatment of cancer, in order to better pinpoint the location of a 
tumor in the body to have enhanced treatment of the disease
8-11
.  One stimuli that is currently be 
explored is the slightly acidic microenvironment around the leaky vasculature of tumor tissue, 
due to a cancer cells increased rates of glycolysis
12
.  The pH for this area ranges from 6.6-7.2; 
slightly depressed from the normal physiological pH of 7.4
12
.  By exploiting this characteristic, 
new methods of cancer imaging and therapy can be developed to better enhance a patients 
quality of care.  
In the Goldberger Group, we are designing and characterizing a new class of stimuli 
responsive self-assembling molecules called Peptide Amphiphiles (PAs) to be used for cancer 
imaging purposes.  PAs are of much interest because of their ability to exist as a single molecule, 
spherical micelle or cylindrical nanofiber depending on their concentration and the pH of the 
environment.  We have designed these molecules in such a way that they have the ability to 
undergo a pH-triggered morphological transition from a micelle to a nanofiber in a slightly acidic 
environment that parallels to that of a tumor
13
.  This transition is vital in order for these 
 [7] 
 
molecules to have enhanced accumulation at the site of the tumor.  Figure 1 shows the overall 
goal and mechanism of these molecules, achieved by a sphere to nanofiber transition in the 
presence of a particular stimulus, specifically the acidic environment of a cancerous tumor. 
 
 
 
 
 
 
 
 
The ability for the PA to exist as a sphere or a nanofiber is essential to our overall goal of 
creating a dynamic self-assembling, stimuli responsive imaging agent.  By having these 
molecules in a micellular morphology, one can exploit the enhanced permeation and retention 
(EPR) effect
14 
as a method of having our material diffuse into the cancerous environment due to 
the permeable blood vessels that exist around the tumor site
15
. This effect depends on the 
molecule’s characteristics that include size (typically 10-30 nm in diameter), zeta potential, 
biocompatibility and solubility
14
.  In order to accomplish this effect, the engineering and design 
of these PAs requires much attention. 
A typical PA consists of an alkyl tail, followed by an amino acid sequence, and 
terminated with a MRI imaging agent (Figure 2). The amino acid sequence contains a 
hydrophobic beta-sheet forming region, followed by an electrostatic charged region. The MRI 
region consists of a Gd
3+
 chelated 1,4,7- tris(carboxymethylaza)cyclododecane-10-
 
Figure 1: Schematic representation of sphere to nanofiber 
transition around a malignant tumor. 
 
 
 [8] 
 
azaacetylamide (DO3A) moiety to allow the molecules to be MRI active
16-18
.   Both the alkyl tail 
and the beta-sheet region promote nanofiber formation, while the charged region promotes 
micelle morphology. All four of these regions (including the MRI region), have an effect on the 
self-assembly properties of the PAs.   The design of the PAs is such that the EPR effect can be 
obtained.  The negatively charged region allows for the zeta potential to be less than zero, while 
the hydrophobic regions allow for slightly decreased solubility, both of which are important for 
the EPR effect.  Also, since these molecules are peptide-lipids, both of which have high 
compatibility within the body, these molecules will be non-cytotoxic.  The size of our PAs 
existing in a micelle morphology has been shown to be 10.0 ± 1.2 nm
13
 which is in the range in 
which the aggregated molecules can easily diffuse into malignant area and the EPR effect can 
take place
14
.  
 
By balancing the attractive hydrophobic and repulsive electrostatic forces in these 
molecules, one could design a vehicle that transforms from a sphere to a nanofiber at a specific 
pH in vivo. However, designing PAs to undergo this pH-specific transition requires a more 
detailed understanding of the PA’s relative forces, and their impact on the self-assembling 
 
Figure 2: Synthesized PA with alkyl tail (black), beta-sheet region (blue), charged region (red) and MRI 
region (green). This PA is palmitoyl-YYAAEEEEK(DO3A:Gd)-NH2. 
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properties of these surfactant-like molecules. To these ends, we have synthesized and 
characterized four different PAs to test how certain structural changes affect the molecule’s 
supramolecular characteristics.  We focused on the alkyl chain length, the number of glutamic 
acids (E) in the charged region and the replacement of a tyrosine (Y) residue by an alanine (A) in 
the beta-sheet region to determine how changes to these areas of the PA affect the sphere to 
nanofiber transitional pH as well as the molecule’s ability to exist as three district morphologies.  
These PAs include palmitoyl-YYAAEEEEK(DO3A:Gd)-NH2 (PA1), palmitoyl-
YYAAEEEEEK(DO3A:Gd)-NH2 (PA2), pentadecyl-YYAAEEEEK(DO3A:Gd)-NH2 (PA3), and 
palmitoyl-YAAAEEEEK(DO3A:Gd)-NH2 (PA4).  Through different analytical techniques and 
characterization methods, phase diagrams were able to be constructed for each of the synthesized 
molecules.  From this, we have a more detailed understanding of how particular changes to these 
molecules affect its morphology at differing concentrations and pH values. 
  
 [10] 
 
Chapter 2: Construction of Phase Diagrams 
 
 All of the PAs for this project were synthesized via solid-phase Fmoc chemistry
19
 and 
purified by reverse-phase high performance liquid chromatography (HPLC).  Their purity was 
determined by analytical HPLC and electrospray ionization time-of-flight mass spectrometry 
(ESI-TOF MS) (Figures S1-2).   
The first PA synthesized was palmitoyl-YYAAEEEEK(DO3A:Gd)-NH2 (PA1).  Because 
of the two neighboring tyrosine (Y) residues in the beta-sheet region, it was thought that this PA 
would self-assemble into a nanofiber relatively easily (at higher pH values) due to tyrosine’s 
high beta-sheet propensity
20-21
.  Circular dichroism (CD) spectroscopy was employed in order to 
determine the morphology of the PA at differing concentrations and pH values
22
. For CD 
measurements, the PA was placed in a 150 mM NaCl, 2.2 mM CaCl2 simulated serum salt 
solution. For PA1, it was found at a wide range of concentrations and pH points, the CD spectra 
showed a beta-sheet curve, one of three readout that are observed in CD
22
.  Spectras of PA1 at 
concentrations of 500 µM and 10 µM, with pH values ranging from 11 to 5 conclude the 
molecule exists as a single morphology by only yielding only a beta sheet curve.  Figure 3 
shows the beta-sheet curve for PA1 at 10 µM over a wide pH range. The beta-sheet curve via CD 
is indicative of a self-assembled nanofiber species, which was confirmed by transmission 
electron microscopy (TEM) of the 500 µM sample (Figure 3 b&c).  
 [11] 
 
The next step in this project 
was to move forward from the results 
observed for PA1 to construct PAs that 
will have decreased hydrophobic 
interactions or increased electrostatic 
repulsions. The hypothesis put forth 
was by taking either of these two 
avenues, the synthesized PA would 
exist as a micelle or single molecule, 
and undergo a transition to a nanofiber 
at decreased pH values. Both of these 
structural changes would lead to the 
synthesized PA to have a lower affinity 
to self-assemble into a nanofiber morphology, thus giving it a higher chance to exist as a micelle 
or single molecule depending on its concentration and the pH of the environment. 
 With this in mind, palmitoyl-YYAAEEEEEK(DO3A:Gd)-NH2 (PA2) was synthesize, 
thus increasing the relative electrostatic repulsions by adding an additional glutamic acid (E) to 
the charged region as compared to PA1.  As a consequence, it was expected that the PA would 
exist as an alternative morphology, such as a micelle or single molecule, as compared to only 
being a nanofiber observed with PA1.  This hypothesis is due to the increase in the electrostatic 
repulsive forces of PA2, thus making it more difficult to self-assembly into a nanofiber.   This 
was confirmed via CD, as it was shown that a transition from a random coil spectrum to a beta-
    a) 
 
b)  c)  
Figure 3: (a) CD of 10 µM PA1, (b) TEM of 500 µM 
PA1 at pH 10, (c) TEM of 500 µM PA1 at pH 5 
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sheet spectrum occurred when the pH was lowered to a more acidic value.  We attribute the 
random coil spectrum to be indicative of a single molecule or spherical micelle.  
From this, we were able to obtain an approximate pH of morphological transition from a 
micelle or single molecule to a nanofiber by taking the midpoint between the lowest pH value of 
a random coil spectrum and the highest pH value a beta-sheet spectrum.  For example, at 50 µM 
for PA2 (Figure 4a), we see the last random coil spectrum (where the y-intercept at 205 nm is 
negative) at a pH 5.80.  We then see the first beta-sheet spectrum (where the y-intercept at 205 
nm is positive) at a pH of 5.69, giving an approximate pH of transition at a value of 5.76.  This 
same process was carried out at 500 µM, 100 µM, and 30 µM.   
 
Since a random coil spectrum can correspond to a single molecule or a micelle, critical 
aggregation concentration (CAC) was employed in order to not only distinguish between these 
two morphologies, but also determine at what concentration PA2 aggregates at a particular pH.  
a)             b) 
 
Figure 4: (a) CD of PA2 at 50 µM in simulated salt serum. (b) CAC of PA2 in salt serum  
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CAC measurements for PA2 were carried out using the pyrene 1:3 method
23
 at pH values of 9, 8, 
7, 6 and 5.  It was observed that at acidic pH values, the CAC was at a lower than at a more basic 
pH. This aligns with the hypothesis that the PA will have a higher affinity to aggregate at lower 
pH values. For example, Figure 4b shows how the CAC at a pH of 9 and 7 compare, as the CAC 
pH 7 was calculated to be 9.37 µM, while at pH 9 the CAC is 21.59 µM. This is due to the 
protonation of the carboxylic acids present in the glutamic acid residues and DO3A moiety, 
leading to decreased electrostatic repulsions at a lower pH. 
From CD and CAC, a phase diagram was able to be constructed detailing PA2’s 
morphology at a given pH and concentration value (Figure 5a). From this we can see a 
concentration dependence on the pH of 
transition from the CD, as well as pH 
dependence on the CAC value.  Once the 
phase diagram was constructed, confirmation 
was needed to show PA2’s distinct 
morphologies. TEM was used to show 
nanofiber formation of 500 µM PA2 at pH 5 
and micelle formation at the same 
concentration at pH 9 (Figure 5b&c).  
The second structural change that we 
made to the PAs, in comparison to PA1, was 
to decrease the attractive forces present in the 
molecule rather than increasing the 
electrostatic forces seen with PA2.  The first 
a) 
 
b)  c)   
Figure 5: (a) Phase Diagram of PA2. Blue 
dimonds: CD, Red squares: CAC. (b) TEM of 
500 µM PA2 at pH 5. (c) TEM of 500 µM PA2 at 
pH 9. 
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way that we accomplished this was by using a pentadecylic acid (C15H30O2) lipid acid as 
opposed to palmitic acid (C16H32O2) for the hydrophobic alkyl tail to synthesize pentadecyl-
YYAAEEEEK(DO3A:Gd)-NH2 (PA3).  The deletion of a single methylene (-CH2) group from 
the alkyl chain was thought to again give PA3 the ability to exist as different morphologies rather 
than only as a nanofiber.  
At 500 µM, CD shows PA3 solely as a nanofiber by only showing a beta-sheet spectrum 
at a wide range of pH values.  However at 100 µM, a random coil spectrum shows at elevated pH 
values a transition to a beta-sheet spectrum occurs at a pH 7.10 (Figure S3). With the CD 
measurements for PA3 at concentrations at 100 µM or less, the beta sheet curve never crossed 
the x-axis, even though there was a minimum at 220 nm (Figure S3). This shows of possible mix 
of morphologies
24
.  However, we attributed 
the pH of transition to be the midpoint at 
which the curves no longer superimposable.   
CAC were carried out on PA3 in the same 
way as PA2 and another phase diagram was 
able to be constructed (Figure 6a).  The 
nanofiber and micelle morphologies at 100 
µM were confirmed by TEM, with clear and 
visible images (Figure 6b&c). 
Recently, a third structural change was 
carried out which parallels the decrease in the 
relative attractive forces relative to PA1. 
palmitoyl-YAAAEEEEK(DO3A:Gd)-NH2 
a)  
 
b)  c)  
Figure 6: (a) Phase Diagram of PA2. Blue 
dimonds: CD, Red squares: CAC (b) TEM of 500 
µM PA2 at pH 5. (c) TEM of 100 µM PA2 at pH 
9. 
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(PA4) was synthesized in order to decrease the beta sheet propensity of the molecule by 
replacing the second tyrosine (Y) residue with an alanine (A) residue  in the beta-sheet region of 
the PA.  Again, by decreasing the attractive forces as compared to PA1, PA4 will have a lower 
affinity to self-assemble into a nanofiber.  The ratio of one highly hydrophobic amino acid, in 
this case Y, to three A residues, to four E residues has been a typical PA sequence for past 
research in our group
13
, which is another reason why we wanted to test the self-assembly profile 
of PA4. As with the other molecules, CD and CAC were carried out of PA4 to construct a third 
phase diagram (Figure 7).  However, more CD points need to be examined in this molecule to 
have a more complete phase diagram.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Figure 7: Phase diagram of PA4. Blue dimonds: CD, 
Red squares: CAC 
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Chapter 3: Comparison of PAs 
 
Circular Dichroism: 
By comparing Circular Dichorism (CD) measurements of the four synthesized PAs, we 
are able to see the differences in their respective sphere to nanofiber transitional pH.  This 
transition is vital for the development of the imaging vehicle we are engineering.  It is to be 
expected that our molecules will exist as a micelle at physiological pH and a nanofiber in slightly 
acidic surroundings. Because of this change in morphology, the sphere to nanofiber transition is 
closely examined for the future direction of this project. 
  
 
 
 
 
 
 
 
 
 
 
For PA1, there was no observable transition noted from the CD, showing only a beta-
sheet curve at a wide range of concentrations and pH values.  Again, this readout is indicative of 
a nanofiber morphology, and was confirmed by TEM.  However, we do see sphere to nanofiber 
pH dependent transitions present in PA2, PA3, and PA4, showing that structural changes from 
 
Figure 8: CD comparison of PA2, PA3 and PA4 
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PA1 allow the molecule to undergo a transition, and not remain as a single morphology.  Figure 
8, shows the CD transitional pH points for the three molecules at different concentrations.  
From this data, we see that for all of the tested PAs, there is a concentration dependence 
on their pH of transition.  This is noted by the more basic transition pH values especially in 
concentrations greater than 30 µM within each respected data set. All three of the PAs with 
transitions show very similar transitional pH values at 30 µM, all being within 0.03 pH units of 
one another, showing possible continuity of the molecules at lower concentrations. We have seen 
this concentration dependence in past PAs that do not have the DO3A:Gd tag attached. However, 
in palmitoyl-IAAAEEEEK(DO3A:Gd)-NH2, there is very little effects of the concentration on 
the pH of transition
13
. Ideally, this is what we are looking for in a delivery vehicle, a PA that will 
transition at or around the same pH regardless of its concentration.  This concentration 
dependence could be attributed to the tyrosine residue(s), as the aromatic and the free hydroxyl 
group could lead to extra pi-pi interactions and hydrogen bond interactions respectively. 
PA2 shows transitional pH points that are shifted to more acidic values in comparison to 
PA3 and PA4.  For example, at 50 µM, PA2 has a sphere to nanofiber transition at pH 5.75, a 
more acidic value compared to the transitional pH of 6.07 in PA3 and 6.82 in PA4.  Also, we see 
a transition at 500 µM for PA2 that we do not see in PA3.  This shows that the addition of a fifth 
glutamic acid to the charged region better allows the molecule to exist as a micelle at higher 
concentrations as compared to the deletion of a single methylene group, and possibly (due to the 
lack of present data), the exchange of a tyrosine residue to an alanine residue. To recall, PA3 
shows only a beta sheet curve at 500 µM, meaning at higher concentrations it exits as a 
nanofiber.  
 [18] 
 
Furthermore, it was discovered that PA4 shows the most basic transitional pH points in 
comparison to PA2 and PA3 at 50 µM. This data shows that the changing of the second tyrosine 
residue to an alanine does not have as great an effect of the pH of transition as compared to 
addition of a fifth glutamic acid (PA2) or the deletion of a methylene group (PA3).  Since PA1, 
PA2 and PA3 have a beta sheet region that follows the sequence -YYAA- the two neighboring 
tyrosine residues could have interactions with one another, thus making the intermolecular 
interactions slightly decreased due to these intramolecular interactions, making it more difficult 
to assemble. The exception would be PA1 because of the lack of high repulsive forces and the 
presence of the palmitic acid tail. However, in PA4, the beta sheet region has the sequence   -
YAAA-, not allowing for the possible intramolecular interactions which would lead more 
intermolecular interactions. These increased intermolecular interactions could be the reason as to 
why PA4 self-assembled easier, or at a higher pH. 
Critical Aggregation Concentration: 
 Through the comparison of Critical Aggregation Concentration (CAC), we are able to see 
how each respective molecule’s affinity to form a micelle from a single molecule compares to 
others. These measurements are important for the future of this project as it tells us at what 
concentration our molecules need to be when injected into a test mouse.  We want theses PAs to 
exist as micelles at physiological pH and knowing what the CAC is for the molecule at that value 
(pH 7.4) as well as other values is important for the development of new PAs and phase 
diagrams.   Figure 9 shows the comparison of the CAC measurements of PA2, PA3 and PA4.   
 [19] 
 
 
 
 
 
 
 
 
 
 
 
From this data, we see at acidic, neutral, and slightly basic conditions, PA4 has a higher 
CAC compared to PA2 and PA3.  For example, at a pH of 7, PA4 has a CAC of 14.08 µM, while 
PA2 and PA3’s CAC correspond to 9.37 µM and 3.89 µM respectively. This shows that at these 
pH values, PA4 has a lower affinity to self-assemble into a micelle as compared to PA2 and 
PA3, meaning that it more prefers to be in a single molecule morphology.  This can be attributed 
to the decreased attractive hydrophobic interactions of PA4 due to only having one tyrosine 
residue, while PA2 and PA3 have two tyrosine residues. The heightened hydrophobic forces 
allows PA2 and PA3 to self-assemble more easily (at lower concentrations) as compared to PA4 
with a decrease in the relative hydrophobic interactions.    At these same pH values, we also see 
PA2 with the next highest CAC, leaving PA3 with the lowest CAC.  This shows that the deletion 
of a single methylene group, with respects to PA1, has the smallest effect on the molecules 
ability to form micelles, if we assume that PA1 has a CAC of nearly zero for all pH values. This 
tells us that PA3 has the strongest tendency to form micelles as compared to PA2 and PA4.  
 
Figure 9: CMC comparison of PA2, PA3, and PA4 
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We do see some discrepancy with the data at higher pH values in which the CAC trends 
previously described do not align.  At a pH of 9, PA3 now has the highest CAC, followed by 
PA2 and finally PA4.  It has been previously shown that at higher pH values the CAC levels off, 
and the degree of difference from one pH value to another is significantly less than in a more 
acidic environment.  We see this in PA4, as the CAC at pH 7 is 14.08 µM and 15.45 µM at pH 9, 
showing little difference as compared to its CAC at pH 7 and at pH 5 (difference of 7.28 µM).  
However, for PA2 and PA3, there is no visible leveling off when it comes to the CAC, as the 
CAC difference for both of these PAs between pH 8 and pH 9 is greater than 9 µM, showing a 
sharp rise rather than a leveling off.  At higher pH values, the five glutamic acids in PA2 will 
most likely all be deprotonated, making it more difficult for the PA to self-assemble.  Likewise 
in PA3, even with four deprotonated glutamic acids, the shortened length of the alkyl tail also 
plays an important role in the molecule’s ability to self-assemble into a micelle. Also the possible 
deprotonation of the two tyrosine residues (pKa = 10.07) could have a large effect on the single 
molecule-to-micelle aggregation.  
Full Phase Diagrams: 
Figure 10 shows all of the CD and CAC data for the three molecules for which phase diagrams 
were constructed.  From this, we can conclude that the data that is obtained from CD cannot be 
transferred to CAC data.  Essentially, it can be stated just because one of our PAs prefers a 
nanofiber morphology compared to a micelle, does not necessarily mean that it also prefers a 
micelle to a single molecule. We see this especially with PA4, as it has a more basic pH of 
transition via CD, but also consistently has the highest CAC.  If we go off of the CD and CAC 
data that was found for PA2 and PA3, it would be expected that PA4 should have the lowest 
 [21] 
 
CAC because of the more basic sphere to nanofiber transitional pH.  This is opposite from what 
we see from the data as PA4 has the highest CAC. 
 
 
 
 
 
 
 
 
 
 
 
 
With PA2 and PA3, we do see that there is a more of an agreement data presented from 
CD and CAC.  PA2 has a more acidic sphere to nanofiber transitional pH as well as a higher 
CAC as compared to PA3.  This shows that PA2 has a lower affinity to self-assemble, either as a 
micelle or nanofiber, than PA3.  Again this shows that the addition of a fifth glutamic acid to the 
molecule’s charged region appears to have a greater effect on the molecule’s ability to self-
assemble rather than a deletion of methylene group from the alkyl tail.   
  
 
Figure 10: Full phase diagram comparison of PA2, PA3, and PA4 
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Chapter 4: Conclusions and Future Work 
 
 In summary, we have been able to synthesize and characterize four different PAs to test 
how structural changes affect their self-assembly properties.  CD and CAC have shown to be 
very effective methods for the construction of phase diagrams to these molecules.  From these 
two methods, we have been able to show how the tested structural changes affect the 
morphological preferences of the PAs at differing concentrations and pH values. From the data, 
we see that all of these tyrosine based PAs show significant concentration dependent self-
assembly properties than what we have previously seen.  Increased the electrostatic forces as 
seen for PA2 shows a sphere to nanofiber transition at lower a pH than the deletion of a 
methylene group from the alkyl chain or the change of a tyrosine residue to an alanine, showing 
increased electrostatic repulsive forces makes it more difficult for the PA to self-assemble to a 
nanofiber than decreasing the attractive forces.   
 For the continuation of this project, more CD data for PA4 would need to be collected to 
test higher concentrations.  These data points will lead to a more complete phase diagram of the 
molecule, thus leading to a better comparison to PA2 and PA3.  Likewise, CD points for PA2 
and PA3 at concentrations less than 30 µM will also lead to more complete data sets.   
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Chapter 5: Supporting Information 
 
(i): Methods  
Synthesis of Peptide Amphiphiles (PA):   
All amino acids and coupling agents were purchased from AnaSpec INC.  The peptides 
were synthesized via solid-phase Fmoc chemistry
19
.  The peptide sequence was built C-Terminus 
to N-Terminus using a Seiber Amide Resin (AAPPTEC) on a 0.5 mmol scale. All of the 
prepared PAs were synthesized manually as outlined in the following paragraph. 
The resin was placed in a shaker vessel and then swollen with dichloromethane (DCM) 
for 30 minutes.  The DCM was removed, and then N, N-Dimethylformanide (DMF) was added 
to the shaker vessel to swell the resin for 30 minutes. Once the DMF was removed, 20% 
piperidine in DMF was added for the deprotection of the Fmoc protecting group and allowed to 
shake for 15 minutes.  The liquid was removed, and replenished to shake for another 15 minute 
interval. The piperidine/DMF solution was removed and the resin was  washed with DCM, DMF 
(2x) and DCM (2x) sequentially.  The removal of the Fmoc protecting group was confirmed via 
a Kaiser Test. The coupling solution for each amino acid contained 4 eq. of O-Benzotriazole 
N,N,N’,N’-tetramethyluroniumhexafluorophosphate (HBTU) or 2-(7-Aza-1H-benzotriazole-1-
ly)-1,1,3,3- tetramethyluronium hexafluorophosphate (HATU), 3.95 eq. of amino acid, 6 eq. of 
N,N- diisopropylethylamine (DIPEA) and 3 drops of Triton X-100 in approximately 10 mL of 
DMF.  This solution was added to the shaker vessel and allowed to couple for 3 hours to the 
deprotected species (amino acid or resin).  The solution was then removed, and the resin was 
washed with DMF (3x) followed by DCM (2x). The coupling of the amino acid was confirmed 
 [24] 
 
by another Kaiser Test.  This process was repeated for each amino acid as well as the palmitic or 
pentadecanoic acid tail. 
Resin Cleavage: 
A 120 mL cleavage mixture was made containing 1% Trifluoroacetic acid (TFA), 2% 
Anisole and 97% DCM.  The cleavage of the peptide from the resin was achieved by adding 20-
25 mL portions of the cleavage mixture to the shaker vessel, and allowing it to shake for 25 
minutes.  After the allotted time, the solution was drained to a round-bottom flask, and another 
portion of the cleavage mixture was added to shake.  Once all of the cleavage mixture was used, 
the TFA/DCM solution in the round-bottom flask was then neutralized with DIPEA.  The excess 
solvent was removed under vacuum and the PA was precipitated out with cold water and cooled 
at 10 °C for 45-60 minutes. The resulting solid was then isolated via vacuum filtration.  
Attachment of DO3A to PAs: 
The solid PA was placed in a round bottom flask, along with 25 mL of pyridine.  The 
mixture was shaken, sonicated, and then stirred in an oil bath at 60 °C for 60 minutes to ensure 
full dissolution of the PA. A coupling solution containing 2 eq. HATU, 2 eq. 1,4,7- 
tris(carboxymethylaza)cyclododecane-10-azaacetylamide (DO3A), 4.4 eq. DIPEA and a small 
portion (2-4 mL) of pyridine were added to the PA. All equivalents were with respect to the PA.  
The mixture was then set to stir for 18-24 hours at room temperature.  To ensure maximal 
coupling, excess solvent was removed under vacuum, until only 10-15 mL of the mixture 
remained.  A second coupling mixture of 2 eq. HATU, 4.4 eq. DIPEA and 1 mL of pyridine was 
added to the PA and stirred for 18-24 hours.  The PA-DO3A was then crashed out with cold 
water and cooled at 10 °C for 45-60 minutes. The resulting PA-DO3A solid was isolated via 
vacuum filtration. 
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Removal of tert-butyl groups on PA:   
A 20 mL solution containing 95% TFA, 3% water and 2% Anisole was prepared and 
added to the PA-DO3A. The mixture was set to stir for 20-24 hours at room temperature in order 
to remove tert-butyl groups from the glutamic acid, tyrosine and DO3A species.  Excess TFA 
was removed under vacuum and the PA-DO3A was crashed out with cold diethyl ether. The 
mixture was cooled at -5°C for 45 minutes and the resulting solid was isolated via vacuum 
filtration. 
Purification of PA-DO3A: 
The crude PA-DO3A (150-250 mg) was dissolved in a 10 mL solution consisting of 9 
mL of water, 1 mL of acetonitrile and a few drops of NH4OH.  This solution was shaken, 
sonicated and vortexed to ensure full dissociation.  The resulting solution was then filtered 
through a 0.45 µm PVDF filter.  Purification of the PA-DO3A was carried out using a Shimadzu 
preparative High Performance Liquid Chromatograph (HPLC) duel pump system controlled by 
LC-MS solution software, with an Agilent PLRP-S polymer column (Model No. PL1212.3100 
150 mm x 25 mm).  The two solvents that were used for the mobile phase were water with 0.1% 
NH4OH (v/v) and acetonitrile with 0.1%NH4OH (v/v).  The product was eluted via a linear 
gradient from 10% acetonitrile to 20% acetonitrile over 22.5 minutes, and then from 20% 
acetonitrile to 40% acetonitrile over an additional 67.5 minutes.  The desired product was 
collected in fractions of 10-15 mL. The presence of the product in the fractions was confirmed 
by a Bruker Electrospray Ionization Time of Flight Mass Spectrometry (ESI-TOF MS) and the 
fractions’ purity was analyzed by a Shimadzu analytical HPLC.  Fractions ≥ 95% in purity were 
added together, acetonitrile was removed under vacuum and the liquid fraction were freeze-dried 
yield a white powder.   
 [26] 
 
Incorporation of Gd
3+
 in PA-DO3A: 
The pure PA-DO3A was dissolved in 4-6 mL of water.  2 eq. of 0.01M GdCl3 in 0.01M 
HCl were added to the PA-DO3A solution.  Diluted NaOH(aq) was added to this solution to set 
the pH at 5.0 - 5.1.  The solution was placed in an oil bath to stir at 60°C.  After 60 minutes, the 
solution was removed from the oil bath, the pH was readjusted to a value of 5.0 – 5.1, and  
placed back in the hot oil bath to stir for 12-18 hours. The solution was then returned to room 
temperature and the pH was raised to a value greater than 10 using 1 M NaOH to precipitate out 
all non-chelated Gd
3+
 to produce solid Gd(OH)3.  The solution was filtered with a 0.45 µm 
PVDF filter and the pH was lowered to a neutral value of approximately 7. 
 
Dialysis of the PA-(DO3A:Gd): 
The PA-(DO3A:Gd) solution was pipetted into a Spectra/Por® Biotech Cellulose Ester 
dialysis membrane (molecular weight cut off: 500 g/mol) and placed in 4 L of Millipore water.  
The water was changed 10-12 times over a 72 hour period.  The dialyzed solution was then 
freeze-dried. The resulting solid yielded the pure PA-(DO3A:Gd)  powder which was confirmed 
through ESI- TOF MS and analytical HPLC. 
 
Circular Dichorism (CD): 
The PA-(DO3A:Gd) solid was dissolved in a aqueous solution of 150 mM NaCl and 2.2 
mM CaCl2, to yield a 0.5 – 1 mM peptide solution.  The resulting solution was then used to 
create diluted samples that included 100, 50, 30 and 10 µM.  The pH was raised in each of the 
solutions to a value greater than 9, stirred in an oil bath at 90 °C for 30 minutes, and then cooled 
to room temperature.  CD measurements were conducted on a JASCO J-815 Spectrometer using 
a 0.5 or 1 cm path length quartz cuvette. Three accumulation were measured at a wavelength 
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range of 260 – 190 nm at a scanning speed of 100 nm/min with an integration time of 2 or 4 
seconds for each data series. A baseline (aqueous salt solution) was subtracted from each of the 
measurements.  Each molecule in this study was analyzed with these parameters at different 
concentration and pH values.  
 
Critical Aggregation Concentration (CAC): 
CAC for the synthesized molecules were determined using the pyrene 1:3 method
23
. CAC 
measurements were taken at pH points of 5, 6, 7, 8, and 9 for each of the molecules tested. 5 mg 
of pyrene were dissolved and mixed in methanol overnight and then diluted with NaCl, CaCl2 
aqueous solutions, and excess water to yield a solution of 150 mM NaCl, 2.2 mM CaCl2 and 62 
µM pyrene. 
For the 500 µM PA-(DO3A:Gd) solution, the pH was raised to a value greater than 9, 
stirred in an oil bath at 90 °C for 30 minutes, and then cooled to room temperature. A 300 µM 
sample was made from this solution.  250 µL of both the 500 µM and 300 µM solutions were 
serial diluted with 150 mM NaCl 2.2 CaCl2 mM aqueous solution. Each of the starting 
concentrations and the diluted mixtures were added to a 96-microwell plate.  5 µL of the pyrene 
solution was added to each of the wells and then stirred to ensure homogeneity.  All of the 
components added to make the samples were at the same pH value in order to test the CAC.  The 
fluorescence emission of the pyrene was monitored by a BioTek Synergy H4 fluorimeter at an 
excitation wavelength of 335 nm. The pyrene fluorescence was monitored from 360 nm to 430 
nm, and the peaks of maximum fluorescence intensity (usually at 376 nm and 392 nm) were 
compared at different concentration values to determine the CAC at a specific pH value.   
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Transmission Electron Microscopy (TEM): 
The PA-(DO3A:Gd) sample (typically 100-500 µM) was raised to a pH value greater 
than 9, stirred in an oil bath at 90 °C for 30 minutes, and then cooled to room temperature.  The 
pH was then adjusted to desired value using HCl and/or NaOH aqueous solution.  Once the pH 
was reached, 5 µL of the sample was placed and spread onto a Carbon Formvar grid (Electron 
Microscopy Sciences) and allowed to sit for 45 seconds before being wicked dry. A 1 wt% 
uranyl acetate solution was added and spread over the grid to negatively stain the sample, and 
was wicked dry immediately after application.  The grid was then examined by a FEI Tecnai G2 
Biotwin TEM.  
 
(ii): Final Product Analysis  
Figure S1: Analytical HPLC of pure PA-(DO3A: Gd) Samples. 
palmitoyl-YYAAEEEEK(DO3A:Gd)-NH2 (PA1) 
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palmitoyl-YYAAEEEEEK(DO3A:Gd)-NH2 (PA2) 
 
 
pentadecyl-YYAAEEEEK(DO3A:Gd)-NH2 (PA3) 
 
 
 palmitoyl-YAAAEEEEEK(DO3A:Gd)-NH2 (PA4)  
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Figure S2: ESI- TOF MS (All in Positive Mode). 
palmitoyl-YYAAEEEEK(DO3A:Gd)-NH2 (MW: 1909.22g/mol) 
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palmitoyl-YAAAEEEEEK(DO3A:Gd)-NH2 (MW: 1818.11 g/mol)  
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Figure S3: Circular Dichorism Data: 
 PA1 at 500 µM in 150 mM NaCl and 2.2 mM CaCl2. 
 
 PA2 at different concentrations in 150 mM NaCl and 2.2 mM CaCl2 for 
phase diagram. 
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 PA3 at different concentrations in 150 mM NaCl and 2.2 mM CaCl2 for 
phase diagram.  
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 PA4 at different concentrations in 150 mM NaCl and 2.2 mM CaCl2 for 
phase diagram.  
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10 µM 
 
 
 
Figure S4: Critical Aggregation Concentration Data 
 PA2 at pH values in 150 mM NaCl and 2.2 mM CaCl2 for phase diagram. 
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 PA3 at pH values in 150 mM NaCl and 2.2 mM CaCl2 for phase diagram 
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 PA4 at pH values in 150 mM NaCl and 2.2 mM CaCl2 for phase diagram 
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Table of CAC for PA2, PA3, and PA4 
 
pH  PA2 CAC (µM) PA3 CAC (µM) PA4 CAC (µM) 
5 0 0 (assumed) 7.28 
6 5.62 1.18 11.31 
7 9.37 3.89 14.08 
8 12.58 12.04  
9 21.59 25.47 15.45 
 
 
Transmission Electron Microscopy: 
 
 PA1 in 150 mM NaCl and 2.2 mM CaCl2 
 
           
       500 µM at pH 5           500 µM at pH 10  
 
 PA2 in 150 mM NaCl and 2.2 mM CaCl2 
 
                
                500 µM at pH 5                               500 µM at pH 9   
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 PA3 150 mM NaCl and 2.2 mM CaCl2 
              
                  500 µM at pH 5                                         500 µM at 9 
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